Q BioMed Inc. (QBIO)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Apr 22, 2025, 4:00 PM EDT

Q BioMed Ratios and Metrics

Millions USD. Fiscal year is Dec - Nov.
Fiscal Year
CurrentFY 2022 FY 2021 FY 2020 FY 2019 FY 2018 2014 - 2017
Period Ending
Apr '25 Nov '22 Nov '21 Nov '20 Nov '19 Nov '18 2014 - 2017
Market Capitalization
0113262728
Upgrade
Market Cap Growth
-81.89%-89.57%-49.78%-3.74%-3.66%-47.12%
Upgrade
Enterprise Value
-1020323127
Upgrade
Last Close Price
0.000.020.451.101.601.95
Upgrade
PS Ratio
0.074.7566.12858.39--
Upgrade
PB Ratio
0.00-0.29-2.76-23.94-5.30-262.64
Upgrade
P/OCF Ratio
0.010.70----
Upgrade
EV/Sales Ratio
-36.01102.501057.67--
Upgrade
Debt / Equity Ratio
-0.63-0.89-0.65-0.09-0.73-27.18
Upgrade
Asset Turnover
0.110.130.270.05--
Upgrade
Quick Ratio
0.000.010.080.100.036.25
Upgrade
Current Ratio
0.000.010.080.130.046.28
Upgrade
Return on Equity (ROE)
------7401.35%
Upgrade
Return on Assets (ROA)
-85.13%-99.58%-644.52%-1300.21%-261.26%-280.17%
Upgrade
Return on Capital (ROIC)
-----709.57%-360.93%
Upgrade
Earnings Yield
-13157.80%-152.09%-63.72%-52.39%-38.42%-33.39%
Upgrade
Buyback Yield / Dilution
-130.36%-67.13%-20.84%-47.34%-9.50%-31.23%
Upgrade
Updated Jun 16, 2023. Source: S&P Global Market Intelligence. Standard template. Financial Sources.